Distinguished in Ulcerative Colitis

Brian L. Bressler

St. Paul's Hospital, 
Vancouver, BC, CA 
Distinguished in Ulcerative Colitis
St. Paul's Hospital, 
Vancouver, BC, CA 
OverviewLocationsClinical Research

Overview

Brian Bressler practices in Vancouver, Canada. Mr. Bressler is rated as a Distinguished expert by MediFind in the treatment of Ulcerative Colitis. His top areas of expertise are Viral Gastroenteritis, Crohn's Disease, Ulcerative Colitis, Colonoscopy, and Endoscopy.

His clinical research consists of co-authoring 165 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 62 articles and participated in 2 clinical trials in the study of Ulcerative Colitis.

Gender
Male

Locations

St. Paul's Hospital, Vancouver, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
Enrollment Status: Active_not_recruiting
Publish Date: September 11, 2025
Intervention Type: Biological
Study Drug: Vedolizumab
Study Phase: Phase 4
A Randomized, Parallel-Group, Non-Inferiority Trial Comparing Random AND Targeted Biopsies to Targeted Biopsies Alone for Neoplasia Screening in Adult Persons With Colonic Inflammatory Bowel Diseases: A Pilot Study
A Randomized, Parallel-Group, Non-Inferiority Trial Comparing Random AND Targeted Biopsies to Targeted Biopsies Alone for Neoplasia Screening in Adult Persons With Colonic Inflammatory Bowel Diseases: A Pilot Study
Enrollment Status: Completed
Publish Date: March 31, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis
Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis
Enrollment Status: Completed
Publish Date: May 20, 2022
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study of QBECO SSI for the Induction and Maintenance of Clinical and Endoscopic Remission in Subjects With Moderate to Severe Crohn's Disease
A Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study of QBECO SSI for the Induction and Maintenance of Clinical and Endoscopic Remission in Subjects With Moderate to Severe Crohn's Disease
Enrollment Status: Terminated
Publish Date: May 18, 2021
Intervention Type: Biological, Other
Study Drug: QBECO Site-Specific Immunomodulators
Study Phase: Phase 2
Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease: A Randomized, Controlled Trial
Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease: A Randomized, Controlled Trial
Enrollment Status: Terminated
Publish Date: April 30, 2021
Intervention Type: Dietary supplement
Study Phase: Not Applicable
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

165 Total Publications

Metabolomics reveal distinct molecular pathways associated with future risk of Crohn's Disease.
Metabolomics reveal distinct molecular pathways associated with future risk of Crohn's Disease.
Journal: Gut microbes
Published: September 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bressler's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile